Brief: Revelation Biosciences Received Nasdaq Notice Stating Co's Common Stock Will Continue To Be Listed, Traded On Nasdaq

Revelation Biosciences

17/02/2023 23:28

Feb 17 (Reuters) - Revelation Biosciences Inc  REVB.O :
    * ON FEB 16, 2023, RECEIVED NASDAQ NOTICE STATING CO'S
COMMON
STOCK WILL CONTINUE TO BE LISTED, TRADED ON NASDAQ

Further company coverage:  REVB.O